Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS)
Clinical trial NCT03669523 · COMPLETED
Trial details
- NCT number
- NCT03669523
- Sponsor
- Centre Hospitalier Annecy Genevois
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-06
- Primary completion
- 2023-10-19
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.